Opinion statement
Stroke during pregnancy is a special category of stroke in young women. Although the absolute risk is small, there are diverse causes, including those inherent to the pregnant state, that may have a significant impact on maternal and fetal outcome. Severe pre-eclampsia and eclampsia are commonly associated with ischemic and hemorrhagic stroke, but must not be presumed the sole cause of stroke in pregnant women. Magnesium sulfate is the treatment of choice to prevent eclampsia. Randomized clinical trials in pregnant women are not available to provide guidance for the treatment of ischemic and hemorrhagic stroke in pregnant women. Various antithrombotic agents may be safely used during specific stages of pregnancy for treatment and prevention of ischemic stroke, with low-dose aspirin, unfractionated heparin, and low molecular weight heparin the preferred agents. Low molecular weight heparin may be safer than unfractionated heparin. Treatment of parenchymatous intracerebral hemorrhage and subarachnoid hemorrhage during pregnancy and the puerperium must be individualized. Aneurysms may be treated with neurosurgical clipping or endovascular coiling, depending on neurosurgical considerations. Cesarean or vaginal delivery may be used depending on the timing of delivery, adequacy of aneurysm occlusion, and risk to mother and fetus. Arteriovenous malformations are best treated in a multimodal fashion at a specialized treatment center.
Similar content being viewed by others
References and Recommended Reading
Kittner SJ, Stern BJ, Wozniak M, et al.: Cerebral infarction in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Neurology 1998, 50:890–894.
Pettiti DB, Sidney S, Quesenberry CP, Bernstein A: Incidence of stroke and myocardial infarction in women of reproductive age. Stroke 1997, 28:280–283.
Stern BJ: Cerebrovascular disease and pregnancy. In Neurological Disorders of Pregnancy, edn 2. Edited by Goldstein PJ, Stern BJ. Mount Kisco: Futura Publishing Co.; 1992.
Cantu C, Baringarrementeria F: Cerebral venous thrombosis associated with pregnancy and the puerperium: review of 67 cases. Stroke 1993, 24:1880–1884.
Donaldson JO, Lee NS: Arterial and venous stroke associated with pregnancy. Neurol Clin 1994, 12:583–599.
Grosset DG, Ebrahim S: Stroke in pregnancy and the puerperium: what magnitude of risk? J Neurol Neurosurg Psych 1995, 58:129–131.
Mas JL, Lamy C: Stroke in pregnancy and the puerperium. J Neurol 1998, 245:305–313.
Bousser MG: Stroke in women: the 1997 Paul Dudley White International Lecture. Circulation 1999, 99:463–467.
Lee RV: Thromboembolic disease and pregnancy: are all women equal? Ann Intern Med 1996, 125:1001–1003.
Simioni P, Prandoni P: The risk of recurrent venous thromboembolism in patients with an Arg 506-Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med 1997, 336:393–403.
Thornburg KL, Jacobson SL, Giraud GD, et al.: Hemodynamic changes in pregnancy. Semin Perinatol 2000, 24:11–14.
Greer IA: The challenge of thrombophilia in maternalfetal medicine. N Engl J Med 2000, 342:424–425.
Shu H, Wramsby M, Bokarewa M, et al.: Decrease in protein C inhibitor activity and acquired APC resistance during normal pregnancy. J Thromb Thrombolysis 2000, 9:277–281.
Lidegaard O: Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: The influence of diabetes, hypertension, migraine and previous thrombotic disease. Br J Obstet Gynecol 1995, 102:153–159.
Sharshar R, Lamy C, Mas JL: Incidence and causes of strokes associated with pregnancy and puerperium: A study in the public hospitals of Ile de France. Stroke 1995, 26:930–936.
Kittner SJ, Stern BJ, Feeser BR, et al.: Pregnancy and the risk of stroke. N Engl J Med 1996, 335:768–774.
Lanska DJ, Kryscio RJ: Peripartum stroke and intracranial venous thrombosis in the National Hospital Discharge Survey. Obstet Gynecol 1997, 89:413–418.
Witlin AG, Friedman SA, Egerman RS, et al.: Cerebrovascular disorders complicating pregnancy: beyond eclampsia. Am J Obstet Gynecol 1997, 176:1139–1148.
Qureshi AI, Giles WH, Croft JB, Stern BJ: Number of pregnancies and risk for stroke and stroke subtypes. Arch Neurol 1997, 54:203–206.
Lanska DJ, Kryscio RJ: Stroke and intracranial venous thrombosis during pregnancy and puerperium. Neurology 1998, 51:1622–1628.
Sameshima H, Nagaya K: Intracranial haemorrhage as a cause of maternal mortality during 1991–1992 in Japan: a report of the Confidential Inquiry into Maternal Deaths Research Group in Japan. Br J Obstet Gynecol 1999, 106:1171–1176.
Lamy C, Hamon JB, Coste J, et al.: Ischemic stroke in young women: Risk of recurrence during subsequent pregnancies. Neurology 2000, 55:269–274.
Kupferminc MJ, Yair D, Bornstein NM, et al.: Transient focal neurological deficits during pregnancy in carriers of inherited thrombophilia. Stroke 2000, 31:892–895.
Witlin AG, Mattar F, Sibai BM: Postpartum stroke: a 20-year experience. Am J Obstet Gynecol 2000, 183:83–88.
Lanska DJ, Kryscio RJ: Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000, 31:1274–1282.
Jaigobin C, Silver FL: Stroke and pregnancy. Stroke 2000, 31:2948–2951.
Ros HS, Lichtenstein P, Bellocco R, et al.: Increased risks of circulatory diseases in late pregnancy and puerperium. Epidemiology 2001, 12:456–460.
Ros HS, Lichtenstein P, Bellocco R, et al.: Pulmonary embolism and stroke in relation to pregnancy: how can high-risk women be identified? Am J Obstet Gynecol 2002, 186:198–203.
Stoodley MA, Macdonald RL, Weir BKA: Pregnancy and intracranial aneurysms. Neurosurg Clin N Am 1998, 9:549–556.
Dias MS, Sekhar LN: Intracranial hemorrhage from aneurysms and arteriovenous malformations during pregnancy and the puerperium. Neurosurgery 1990, 27:855–866.
Dias M: Neurovascular emergencies in pregnancy. Clin Obstet Gynecol 1994, 37:337–354.
Roberts J: Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998, 16:5–15.
Roberts JM, Cooper DW: Pathogenesis and genetics of pre-eclampsia. Lancet 2001, 357:53–56.
National High Blood Pressure Education Program: Report of the National High Blood Pressure Education Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000, 183:S1-S22.
Lain KY, Roberts JM: Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 2002, 287:3183–3186.
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC VII report. JAMA 2003, 289:2560–2572. Latest recommendations for the treatment of hypertension.
Richards A, Graham D, Bullock R: Clinicopathological study of neurological complications due to hypertensive disorders of pregnancy. J Neurol Neurosurg Psych 1988, 51:416–421.
Hinchey J, Chaves C, Appignani B, et al.: A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996, 334:494–500.
Drislane FW, Wang AM: Multifocal cerebral hemorrhage in eclampsia and severe pre-eclampsia. J Neurol 1997, 244:194–198.
Sun JCL, Yakimov M, Al-Badawi I, Honey CR: Hemorrhagic moyamoya disease during pregnancy. Can J Neurol Sci 2000, 27:73–76.
Sengar AR, Gupta RK, Dhanura AK, et al.: MR imaging, MR angiography, and MR spectroscopy of the brain in eclampsia. Am J Neuroradiol 1997, 18:1485–1490.
Schaefer PW, Buonanno FS, Gonzalez RG, Schwamm LH: Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997, 28:1082–1085.
Digre K, Varner M, Osborn A, et al.: Cranial magnetic resonance imaging in severe preeclampsia vs. eclampsia. Arch Neurol 1993, 50:399–406.
Collaborative Low-dose Aspirin Study in Pregnancy Group: A randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994, 343:619–629.
Rotchell YE, Cruickshank JK, Gay MP, et al.: Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomized trial for the prevention of pre-eclampsia and its complications. Br J Obstet Gynecol 1998, 105:286–292.
Golding J: A randomized trial of low dose aspirin for primiparae in pregnancy. Br J Obstet Gynecol 1998, 105:293–299.
Qureshi AI, Frankel MR, Ottenlips JR, Stern BJ: Cerebral hemodynamics in preeclampsia and eclampsia. Arch Neurol 1996, 53:1226–1231.
Keunen RWM, Vliegen JHR, Gerretsen G, Smith SJ: Cerebral vasospasm and vasodilatation in pre-eclampsia. J Neurol 1997, 244:352–353.
Belfort MA, Tooke-Miller C, Allen JC Jr, et al.: Changes in flow velocity, resistance indices, and cerebral perfusion pressure in the maternal middle cerebral artery distribution during normal pregnancy. Acta Obstet Gynecol Scand 2001, 80:104–112.
Belfort MA, Saade GR, Grunewald C, et al.: Effects of blood pressure on orbital and middle cerebral artery resistances in healthy pregnant women and women with preeclampsia. Am J Obstet Gynecol 1999, 180:601–607.
Belfort MA, Saade GR, Grunewald C, et al.: Association of cerebral perfusion pressure with headache in women with preeclampsia. Br J Obstet Gynecol 1999, 106:814–821.
Belfort MA, Saade GR, Yared M, et al.: Change in estimated cerebral perfusion pressure after treatment with nimodipine or magnesium sulfate in patients with preeclampsia. Am J Obstet Gynecol 1999, 181:402–407.
Belfort MA, Varner MW, Dizon-Townson DS, et al.: Cerebral perfusion pressure, and not cerebral blood flow, may be the critical determinant of intracranial injury in preeclampsia: a new hypothesis. Am J Obstet Gynecol 2002, 187:626–634. The theory of pathogenesis of pre-eclampsia based on transcranial Doppler findings.
Easton JD: Severe preeclampsia/eclampsia: hypertensive encephalopathy of pregnancy? Cerebrovasc Dis 1998, 8:53–58.
The Eclampsia Trial Collaborative Group: Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995, 345:1455–1463.
Lucas MJ, Leveno KJ, Cunningham FG: A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995, 333:201–205.
Coetzee EJ, Dommisse J, Anthony J: A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia. Br J Obstet Gynecol 1998, 105:300–303.
The Magpie Trial Collaborators: Do women with preeclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomized placebocontrolled trial. Lancet 2002, 359:1877–1890. Important clinical trial data.
Belfort MA, Anthony J, Saade GR, Allen JC: A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 2003, 348:304–311. Important clinical trial data.
Garner BF, Burns P, Bunnung RD, Laureno R: Acute blood pressure elevation can mimic arteriographic appearance of cerebral vasculitis (a postpartum case with relative hypertension). J Rheumatol 1990, 17:93–97.
Brick JF: Vanishing cerebrovascular disease of pregnancy. Neurology 1988, 38:804–806.
Bogousslavsky J, Despland PA, Regli F, Dubuis PY: Postpartum cerebral angiopathy: reversible vasoconstriction assessed by transcranial Doppler ultrasounds. Eur Neurol 1989, 29:102–105.
Geraghty JJ, Hoch DB, Robert ME, Vinters HV: Fatal puerperal cerebral vasospasm and stroke in a young woman. Neurology 1991, 41:1145–1147.
Barinagarramenteria F, Cantu C, Balderrama J: Postpartum cerebral angiopathy with cerebral infarction due to ergonovine use. Stroke 1992, 23:1364–1366.
Raps EC, Galetta SL, Broderick M, Atlas SW: Delayed peripartum vasculopathy: cerebral eclampsia revisited. Ann Neurol 1993, 33:222–225.
Ursell MR, Marras CL, Farb R, et al.: Recurrent intracranial hemorrhage due to postpartum cerebral angiopathy: implications for management. Stroke 1998, 29:1995–1998.
Roh JK, Park JS: Postpartum cerebral angiopathy with intracerebral hemorrhage in a patient receiving lisuride. Neurology 1998, 50:1152–1154.
Lee KY, Sohn YH, Kim SH, Sunwoo IN: Basilar artery vasospasm in postpartum cerebral angiopathy. Neurology 2000, 54:2003–2005.
Modi M, Modi G: Postpartum cerebral angiopathy in a patient with chronic migraine with aura. Headache 2000, 40:677–681.
Akins PT, Levy K, Cross AH, et al.: Postpartum cerebral vasospasm treated with hypervolemic therapy. Am J Obstet Gynecol 1996, 175:1386–1388.
Ringer AJ, Qureshi AI, Kim SH, et al.: Angioplasty for cerebral vasospasm from eclampsia. Surg Neurol 2001, 56:373–379.
Calabrese LH, Furlan AJ, Gragg LA, Ropos TJ: Primary angiitis of the central nervous system: diagnostic criteria and clinical approach. Cleve Clin J Med 1992, 59:293–306.
Adams HP Jr, Adams RJ, Brott T, et al.: Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003, 34:1056–1083. Excellent review of modern management for acute ischemic stroke.
Kearon C, Crowther M, Hirsh J: Management of patients with hereditary hypercoagulable disorders. Ann Rev Med 2000, 51:169–185.
Gerhardt A, Scharf RE, Beckmann MW, et al.: Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000, 342:374–380.
Savelieva GM, Efimov VS, Grishin VL, et al.: Blood coagulation changes in pregnant women at risk of developing preeclampsia. Intl J Gynecol Obstet 1995, 48:3–8.
Clark P, Sattar N, Walker ID, Greer IA: The Glasgow Outcome, APCR and Lipid (GOAL) Pregnancy Study: significance of pregnancy associated activated protein C resistance. Thromb Haemost 2001, 85:30–35.
Clark P, Twaddle S, Walker ID, et al.: Cost-effectiveness of screening for the factor V Leiden mutation in pregnant women. Lancet 2002, 359:1919–1920.
Ginsberg JS, Greer I, Hirsh J: Use of antithrombotic agents in pregnancy. Chest 2001, 119:122S-131S.
Rai R, Cohen H, Dave M, Regan L: Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997, 314:253–257.
Wardlaw J: Overview of Cochrane thrombolysis metaanalysis. Neurology 2001, 57:S69-S76.
Furlan AJ, Higashida R, Wechsler L, et al.: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II Study: a randomized controlled trial. JAMA 1999, 282:2003–2011. Important clinical trial that shows that superselective intraarterial fibrinolysis works.
Elford K, Leader A, Wee R, Stys PK: Stroke in ovarian hyperstimulation syndrome in early pregnancy treated with intra-arterial rt-PA. Neurology 2002, 59:1270–1272.
Turrentine MA, Braems G, Ramirez MM: Use of thrombolytics for the treatment of thromboembolic disease during pregnancy. Obstet Gynecol Surv 1995, 50:534–541.
Khamashta MA, Cuadrado MJ, Mujic F, et al.: The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995, 332:993–997.
Albers G, Amarenco P, Easton JD, et al.: Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 2001, 119:300S-320S.
Sanson BJ, Lensing AWA, Prins MH, et al.: Safety of lowmolecular-weight heparin in pregnancy: a systematic review. Thromb Haemost 1999, 81:668–672.
Chan WS, Anand S, Ginsberg JS: Anticoagulation of pregnant women with prosthetic heart valves: a systematic review of the literature. Arch Intern Med 2000, 160:191–196.
Sherman D: Long-term anticoagulation therapy in prevention of stroke. Curr Treat Options Neurol 2002, 4:411–416.
Ferro JM: Cardioembolic stroke: an update. Lancet 2003, 2:177–188.
Mohr JP, Thompson JLP, Lazar RM, et al.: A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001, 345:1444–1451.
Mas JL, Arquizan C, Lamy C, et al.: Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001, 345:1740–1746.
Homma S, Sacco RL, DiTullio MR, et al.: PICSS-PFO in cryptogenic stroke study. Circulation 2002, 105:2625–2631.
Kutteh WH: Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996, 174:1584–1589.
Brey R: Preliminary concordance between antiphospholipid (aPL) assays in a subset of ischemic stroke patients enrolled in the WARSS/APASS collaboration. jtStroke 2002, in press.
Watson WJ, Freeman J, O’Brien C, Benson M: Embolic stroke in a pregnant patient with a mechanical heart valve on optimal heparin therapy. Am J Perinatol 1996, 13:371–372.
Einhaupl KM, Villringer A, Meister W, et al.: Heparin treatment in sinus venous thrombosis. Lancet 1991, 338:597–600.
de Bruijn SFTM, Stam J: Randomized, placebo-controlled trial of anticoagulant treatment with lowmolecular-weight heparin for cerebral sinus thrombosis. Stroke 1999, 30:484–488.
Bousser MG: Cerebral venous thrombosis: nothing, heparin, or local thrombolysis? Stroke 1999, 30:481–483.
Chow K, Gobin YP, Saver J, et al.: Endovascular treatment of dural sinus thrombosis with rheolytic thrombectomy and intra-arterial thrombolysis. Stroke 2000, 31:1420–1425.
Preter M, Tzuorio C, Ameri A, et al.: Long-term prognosis in cerebral venous thrombosis. Stroke 1996, 27:243–246.
Broderick JP, Adams HP, Barsan W, et al.: Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999, 30:905–915.
Fernandes HM, Gregson B, Siddique S, Mendelow AD: Surgery in intracerebral hemorrhage: the uncertainty continues. Stroke 2000, 31:2511–2516.
Diringer MN, Edwards DF: Admission to a neurological/ neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med 2001, 29:635–640.
Mayberg MR, Batjer HH, Dacey R, et al.: Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994, 25:2315–2328.
Bendok BR, Getch CC, Malisch TW, et al.: Treatment of aneurysmal subarachnoid hemorrhage. Semin Neurol 1998, 18:521–531.
Weir B, Macdonald RL: Management of intracranial aneurysms and arteriovenous malformations during pregnancy. In Neurosurgery. Edited by Wilkins RH, Rengachary SS. New York: McGraw-Hill; 1996:2421–2427.
van Gijn J, Rinkel GJE: Subarachnoid hemorrhage: diagnosis, causes, and management. Brain 2001, 124:249–278.
Brilstra EH, Rinkel GJE, van Rooij WJJ, et al.: Treatment of intracranial aneurysms by embolization with coils: a systematic review. Stroke 1999, 30:470–476.
International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group: International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial. Lancet 2002, 360:1267–1274. Important clinical trial data suggesting endovascular coiling may be superior to clipping.
Rinkel GJE, Djibuti M, Algra A, van Gijn J: Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 1998, 29:251–256.
The International Study of Unruptured Intracranial Aneurysms Investigators: Unruptured intracranial aneurysms: risk of rupture and risks of surgical intervention. N Engl J Med 1998, 339:1725–1733.
The Magnetic Resonance Angiography in Relatives of Patients with Subarachnoid Hemorrhage Study Group: Risks and benefits of screening for intracranial aneurysms in first-degree relatives of patients with sporadic subarachnoid hemorrhage. N Engl J Med 1999, 341:1344–1350.
Yoshimoto Y, Wakai S: Cost-effectiveness analysis of screening for asymptomatic, unruptured intracranial aneurysms: a mathematical model. Stroke 1999, 30:1621–1627.
Tsutsumi K, Ueki K, Usui M, et al.: Risk of subarachnoid hemorrhage after surgical treatment of unruptured intracranial aneurysms. Stroke 1999, 30:1181–1184.
Raaymakers TW, Rinkel GJ, Limburg M, et al.: Mortality and morbidity of surgery for unruptured intracranial aneurysms: a meta-analysis. Stroke 1998, 29:1531–1538.
Bederson JB, Awad IA, Wiebers DO, et al.: Recommendations for the management of patients with unruptured intracranial aneurysms: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 2000, 102:2300–2308.
Johnston SC, Dudley RA, Gress DR, Ono L: Surgical and endovascular treatment of unruptured cerebral aneurysms at university hospitals. Neurology 1999, 52:1799–1805.
Johnston SC, Gress DR, Kahn JG: Which unruptured aneurysms should be treated? A cost-utility analysis. Neurology 1999, 52:1806–1815.
Johnston SC, Wilson CB, Halbach VV, et al.: Endovascular and surgical treatment of unruptured cerebral aneurysms: comparison of risks. Ann Neurol 2000, 48:11–19.
Al-Shahi R, Warlow C: A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain 2001, 124:1900–1926.
Fleetwood IG, Steinberg GK: Arteriovenous malformations. Lancet 2002, 359:863–873.
Ogilvy CS, Stieg PE, Awad I, et al.: Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2001, 32:1458–1471.
Graham GD: Arteriovenous malformations in the brain. Curr Treat Options Neurol 2002, 4:435–444.
Horton J, Chambers W, Lyons S, et al.: Pregnancy and the risk of hemorrhage from cerebral arteriovenous malformations. Neurosurgery 1990, 27:867–872.
Forster D, Kunkler I, Hartland P: Risk of cerebral bleeding from arteriovenous malformations in pregnancy: the Sheffield experience. Stereotact Funct Neurosurg 1993, 61(suppl):20–22.
Finnerty JJ, Chisholm CA, Chapple H, et al.: Cerebral arteriovenous malformations in pregnancy: presentation, and neurologic, obstetric, and ethical significance. Am J Obstet Gynecol 1999, 181:296–303.
Sawin PD: Spontaneous subarachnoid hemorrhage in pregnancy. In Neurosurgical Aspects of Pregnancy, edn 1. Edited by Loftus CM. Park Ridge: American Association of Neurological Surgeons; 1996:85–100.
Uchide K, Terada S, Akasofu K, et al.: Cerebral arteriovenous malformations in a pregnancy with twins: case report. Neurosurgery 1992, 31:780–782.
Sharma S, Herrera E, Sidawi J, et al.: The pregnant patient with an intracranial arteriovenous malformation: cesarean delivery using regional or general anesthesia? Reg Anesth 1995, 20:455–458.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sloan, M.A., Stern, B.J. Cerebrovascular disease in pregnancy. Curr Treat Options Neurol 5, 391–407 (2003). https://doi.org/10.1007/s11940-003-0030-z
Issue Date:
DOI: https://doi.org/10.1007/s11940-003-0030-z